4th Annual Clinical
Pharmacology in the Management of Cardiovascular Disease:
Diabetes, Depression, HIV and Post-Transplant Challenges
In conjunction
with ACC.09 and the i2 Summit
In Cooperation with:
Program Director: Janet B. Long, MSN, ACNP, CLS,
FAHA
March
28, 2009
The Rosen Centre Hotel
Orlando, Florida
PROGRAM
OVERVIEW
Statement of Need
Cardiovascular disease is now the primary cause of death
and disability worldwide. According to the World Health Organization,
17.5 million people died from cardiovascular disease in 2005, representing
30 percent of global deaths. That number is likely to rise to 20
million by 2015. The presence of additional risk factors from diabetes,
depression and HIV infection, as well as the challenges patients
face after transplants, increases this morbidity risk. Management
of this growing population requires that the entire cardiac care
team have knowledge and competence in pharmacology.
The American College of Cardiology is committed to improving patient
outcomes, and continues to provide quality educational activities
by once again offering the 4th Annual Clinical Pharmacology
in the Management of Cardiovascular Disease.
Overview
A Prelude to ACC.09 –
Arrive Friday night and earn pharmacology CE and CME credits on
Saturday!
Maximize your time in Orlando with a program focusing on the interaction
between cardiovascular disease and depression, diabetes, HIV and
post-transplant challenges. Cardiologists, pharmacists and other
cardiovascular professionals will have the opportunity to hear from
the experts and their peers about optimal pharmacological approaches
to disease management. This program will discuss medication classes
and disease states as they relate to cardiovascular disease, whether
directly or indirectly as a result of drug interactions, co-morbidity
or direct treatment of the disease. Based on extensive current pharmacologic
research, clinical trials and actual cases, this interactive program
is designed to foster a collaborative approach to patient care.
Learner Objectives
The overall goal of this program is to enhance knowledge competency
in the practice of optimal pharmacological approaches to disease
management.
Upon completion of this program, attendees should be able to —
- Explain the pharmacokinetics for cardiovascular medications
and the impact of also treating HIV, depression, diabetes or post-transplant
challenges
- Discuss the treatment for HIV and potential drug interactions
with protease inhibitors
- Identify potential adverse reactions in post-transplant patients
with antihypertensive and lipid medications
- Identify potential drug interactions from anti-depressants alone
and in combination with other cardiovascular medications
- Identify anti-depressants that cause prolonged QT intervals
on the EKG
- Discuss the benefits of hypoglycemic medications in the treatment
of diabetes
- Recognize potential drug interactions of hypoglycemic medications
with cardiovascular disease related medications
- Plan the optimal pharmacologic management for patients with
co-morbid diseases
- Discuss drug benefits and interactions
FACULTY
Program Director
Janet B. Long, MSN, ACNP, CLS, FAHA
Nurse Practitioner
Co-director of the Cardiovascular Risk Reduction Program
Rhode Island Cardiology Center
Providence, RI
Invited Faculty
Anthony Busti, PharmD, BSN, BCPS
Clinical Pharmacologist
Dallas VA Research Unit
Adjunct Professor
Baylor University, College of Graduate Nursing
Texas Woman's University, College of Graduate Nursing
Dallas, TX
Rhonda Cooper-DeHoff, PharmD, MS, FAHA
Research Associate Professor
Assistant Director of Clinical Research
Division of Cardiovascular Medicine
University of Florida
Gainesville, FL
David Parra, PharmD, BCPS
Clinical Pharmacy Specialist in Cardiology
West Palm Beach Veterans Administration Medical Center
Section of Clinical Pharmacology
West Palm Beach, FL
Donna Polk, MD, MPH, FACC
Director of Preventive Cardiology
Director of Women’s Heart
Hartford Hospital
Hartford, CT
Robert Talbert, PharmD, FCCP, BCPS
Professor, College of Pharmacy
University of Texas-Austin
Professor, School of Medicine
University of Texas-San Antonio
University of Texas Health Science Center at San Antonio
San Antonio, TX
DISCLOSURES
ACCF faculty, committee members, staff and other
individuals who are in a position to control the content of this
activity are required to disclose all real or apparent conflicts
of interest. All relevant potential conflicts of interest that are
identified are thoroughly vetted through a process that includes
course directors and appropriate peer review by education committee
chairs/members, for fair balance, scientific objectivity and validity,
patient care and safety recommendations. ACCF staff involved with
this program have nothing to disclose. Refer to the links below
for committee members and faculty disclosures.
ACC
Live Programs Committee (2007-2010) disclosures
4th Annual
Clinical Pharmacology in the Management of Cardiovascular Disease:
Diabetes, Depression, HIV and Post-Transplant Challenges
LEARNER BILL OF RIGHTS
Learner Bill
of Rights
AGENDA
Click here
for agenda.
TARGET
AUDIENCE
This program is intended for physicians, advance
practice nurses, physician assistants, pharmacists and other members
of cardiac care teams.
ACCREDITATION
Physicians
The American College of Cardiology Foundation is accredited by the
Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
The ACCF designates this educational activity for a maximum of
8 AMA PRA Category 1 Credits™. Physicians should
only claim credits commensurate with the extent of their participation
in the activity.
Nurses
The American College of Cardiology Foundation is accredited as a
provider of continuing nursing education by the American Nurses
Credentialing Center’s Commission on Accreditation.
The ACCF designates this educational activity for a maximum of
8 continuing education hours. Requirements for successful completion
are attendance in a session in its entirety and completing the evaluation
tool. Each attendee should only claim credits commensurate with
the extent of their participation in the activity.
 Pharmacists
University of Florida College of Pharmacy is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy
education. The ACPE Universal Program Number is 012-999-08-132-01-P.
This program provides 8 contact hours (0.8 CEU's) of continuing
education credit. You must pre-register with the American College
of Cardiology to attend this program. Continuing education statements
of credit will be mailed by the University of Florida College of
Pharmacy in 4-6 weeks to participants who have attended the seminar
and completed an activity evaluation form.
Each attendee should only claim credits commensurate with the extent
of their participation in the activity.
REGISTRATION
To Register On Line for the Program click
here.
To Register by Fax, Email or Phone for the Program click
here.
ACCOMMODATIONS
Hotel accommodations can be made through the 2009
Conference site at http://acc09.acc.org
GENERAL
INFORMATION
Tuition
The registration tuition includes continental breakfast, refreshment
break, lunch and the syllabus.
Registration Cancellations, Substitutions and Refunds
All requests for refunds for cancellation or registration category
adjustments will be processed, less a $50 administrative fee. Registration
tuition is non-refundable after February 18, 2009. Cancelled registrations
are nontransferable.
In cases of emergency, all refund requests received after February
18, 2009 will be processed on a case-by-case basis once the College
returns from ACC.09 and i2 Summit in Orlando. All refund requests
must be received at the ACC in writing no later than June 30, 2009
in order to be considered.
In the unlikely event that the program is canceled, the College
will refund the registration tuition in full but is not responsible
for any travel or hotel costs you may incur.
ACCF reserves the right to cancel programs in the unlikely event
of insufficient enrollment or other unforeseen circumstances. If
a program is canceled or postponed, ACCF will refund registration
tuition but cannot be held responsible for other costs or expenses,
including cancellations/change penalties assessed by airlines, travel
agencies or hotels.
Please Note
Smoking is prohibited in all ACCF meeting rooms.
Videotaping, audiotaping and still photography are prohibited in
all ACCF meeting rooms.
We encourage participation by all individuals. If you have a disability,
advance notification of any special needs will help us serve you
better.
Faculty and program are subject to change without notice. Views
expressed in this program are those of the individual speaker and
do not necessarily reflect views of the ACCF.
ACKNOWLEDGMENTS
Major Program support provided by the following:
At the time of posting, a complete listing of supporters was not
available. Appropriate acknowledgment will be updated upon confirmation
of support and at the time of the program. | 
